Literature DB >> 7540070

Sialylated O-glycans and L-selectin sequentially mediate myeloid cell rolling in vivo.

K Ley1, A Zakrzewicz, C Hanski, L M Stoolman, G S Kansas.   

Abstract

Leukocyte rolling precedes firm adhesion and emigration in inflammatory cell recruitment. Both P-selectin, an endothelial lectin that binds to sialylated O-glycans containing sialyl-Lewisx (sLex) on the granulocyte surface, and leukocyte L-selectin have been shown to mediate leukocyte rolling in vivo. Here, we investigate rolling of isolated human neutrophils (PMN), HL-60 promyelocytes, and an L-selectin-transfected cell line (300.19-L) during trauma-induced inflammation in rat mesenteric venules. HL-60 cells, which express no L-selectin but abundant sLex, rolled effectively immediately after abdominal surgery. HL-60 cell rolling was almost completely abolished by pretreatment with sialidase or monoclonal antibody (MoAb) AM-3 recognizing sLex, and was reduced by about 80% by O-sialoglycoprotein-endopeptidase (OSGP). By contrast, 300.19-L cells rolled poorly immediately after surgery but rolled well between 40 and 120 minutes after surgery. Their rolling was completely inhibited by the blocking L-selectin MoAb LAM1-3, but not by a binding control MoAb. PMN express both L-selectin and clustered, sialylated glycoproteins including P-selectin glycoprotein ligand-1 (PSGL-1). PMN showed effective rolling at all times, which was abolished by sialidase or MoAb AM-3 pretreatment during the first 30 minutes after surgery, but not later, when PMN rolling was largely L-selectin-dependent. We conclude that in trauma-induced inflammation, a two-step mechanism accounts for most of myeloid cell rolling, which initially requires O-glycans and subsequently depends on L-selectin function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540070

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Biomechanics of leukocyte rolling.

Authors:  Prithu Sundd; Maria K Pospieszalska; Luthur Siu-Lun Cheung; Konstantinos Konstantopoulos; Klaus Ley
Journal:  Biorheology       Date:  2011       Impact factor: 1.875

2.  Neonatal sepsis and neutrophil insufficiencies.

Authors:  John Nicholas Melvan; Gregory J Bagby; David A Welsh; Steve Nelson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2010-06       Impact factor: 5.311

Review 3.  Selectin-carbohydrate interactions during inflammation and metastasis.

Authors:  R P McEver
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment.

Authors:  S D Robinson; P S Frenette; H Rayburn; M Cummiskey; M Ullman-Culleré; D D Wagner; R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.

Authors:  Won Ho Yang; Claudia Nussbaum; Prabhjit K Grewal; Jamey D Marth; Markus Sperandio
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

6.  Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8.

Authors:  Cheng Dong; Margaret J Slattery; Shile Liang; Hsin-Hsin Peng
Journal:  Mol Cell Biomech       Date:  2005-09

7.  Neutrophils influence melanoma adhesion and migration under flow conditions.

Authors:  Margaret J Slattery; Cheng Dong
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

8.  Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans.

Authors:  L Giuffrè; A S Cordey; N Monai; Y Tardy; M Schapira; O Spertini
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

9.  The manifold roles of sialic acid for the biological functions of endothelial glycoproteins.

Authors:  Marco D'Addio; Jasmin Frey; Vivianne I Otto
Journal:  Glycobiology       Date:  2020-07-16       Impact factor: 4.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.